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Among multiple genes aberrantly activated in cancers, invariably, there is a group related to the capacity of cell to
self-renewal. Some of these genes are related to the normal process of development, including the establishment
of a germline. This group, a part of growing family of Cancer/Testis (CT) genes, now includes the meiosis specific
subunits of cohesin complex. The first reports characterizing the SMC1 and RAD21 genes, encoding subunits of
cohesin, were published 20 years ago; however the exact molecular mechanics of cohesin molecular machine
in vivo remains rather obscure notwithstanding ample elegant experiments. The matters are complicated by the
fact that the evolution of cohesin function, which is served by just two basic types of protein complexes in
budding yeast, took an explosive turn in Metazoa. The recent characterization of a new set of genes encoding
cohesin subunits specific for meiosis in vertebrates adds several levels of complexity to the task of structure-
function analysis of specific cohesin pathways, even more so in relation to their aberrant functionality in cancers.
These three proteins, SMC1β, RAD21L and STAG3 are likely involved in a specific function in the first meiotic
prophase, genetic recombination, and segregation of homologues. However, at present, it is rather challenging to
pinpoint the molecular role of these proteins, particularly in synaptonemal complex or centromere function, due to
the multiplicity of different cohesins in meiosis. The roles of these proteins in cancer cell physiology, upon their
aberrant activation in tumors, also remain to be elucidated. Nevertheless, as the existence of Cancer/Testis cohesin
complexes in tumor cells appears to be all but certain, this brings a promise of a new target for cancer therapy
and/or diagnostics.
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Cohesin is a protein complex that is essential for cell
proliferation in all eukaryotic cells. Cohesin is the key
activity that establishes sister chromatid cohesion (SCC)
and then holds sister chromatids until the anaphase. The
separation of sister chromatids in mitotic cell division
requires the inactivation of SCC function by either pro-
teolytic cleavage or stripping cohesin molecules from
chromatin. The original (“mitotic” or “somatic”) cohesin
complex is postulated to have the shape of a “ring” that
is potentially able to physically embrace two chromatids
[1]. All cohesin complexes are composed of four essen-
tial subunits. The chromatid-embracing core of the ring-
like structure is formed by two SMC proteins, SMC1
and SMC3, which belong to the family of SMCCorrespondence: alex@gibh.org
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reproduction in any medium, provided the or(Structural Maintenance of Chromosomes) ATP-binding
proteins [2]. SMC1 and SMC3 heterodimerize by joining
via their hinge domains [3]. The “locking” of the ring is
achieved via binding of two ATP molecules at the ATP-
binding domains of SMC1 and SMC3 [4]. Such a locking
of the ring is facilitated by the third subunit that is
known as RAD21/SCC1/MCD1 in a variety of systems
[5-7]. This very subunit is the target of proteolytic cleav-
age by the separase/separin coincidental with anaphase
initiation [8-10]. The forth core cohesin subunit is a
HEAT repeat protein known as SCC3 in yeast [11], and
represented in vertebrates by two paralogs, SA1/STAG1
and SA2/STAG2 [12,13]. The functionality of mitotic/
somatic cohesin is well studied with respect to its in-
volvement in SCC at the centromeres. The molecular
role of cohesin at the chromosomal arms is more ob-
scure, however it has been directly linked to DNA repair
[14] and, albeit less conclusively, to many instances oftd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cohesin, in yet to be uncovered fashion, facilitates the
function of the multipurpose transcriptional regulator
CTCF [19], at a subset of thousands of CTCF sites in
the genomes of Metazoa where cohesin and CTCF
colocalize [20,21]. However, as CTCF itself is a multi-
functional protein, delineating the molecular pathway
linking cohesin to gene expression regulation has proven
rather difficult. Furthermore, while the differential func-
tions of SA1/STAG1 and SA2/STAG2 are not well de-
fined, the most recent data indicate that SA1/STAG1,
but not SA2/STAG2, is somehow linked to cohesin
colocalization with CTCF [22].
With the exception of still unclear mechanistic links to
non-SCC mediated processes, such as transcription, the
biggest splash since the characterization of cohesin in
the 1990s was made with the discovery of the meiotic
function of cohesin. Indeed, upon entering meiosis I, in
the preparation for the reductional division, a meiosis-
specific subunit REC8 de facto replaces RAD21/SCC1/
MCD1 and makes mei-cohesin to behave rather differ-
ently with respect to timing of SCC1 release. Namely,
REC8 protects SCC throughout the process of homolo-
gous recombination and then maintains the association
of homologues after recombination is complete, up to
the point when chromosomes are ready to segregate. At
this point, REC8-mediated cohesion is released along the
arms, but persists at the centromeres to ensure proper
sister chromatid orientation in meiosis II [23-25]. In
yeast, REC8 is known to have some functions in addition
to SCC per se, including chromosomal restructuring
leading to recombination: assembly of axial elements,
pairing and synapsis of homologues. Yeast REC8 can
easily take the place of SCC1/MCD1 in the SMC1/
SMC3 complex in vitro [26], however in vivo studies in
mice show that there is little, if any, exchange of REC8
once it becomes chromatin-bound [27]. In general, in
metazoan systems, the rebuilding of cohesin for meiosis
is much more complex, evidently due to the evolution-
ary emergence of the sophisticated germline develop-
ment process. In addition to REC8 [28], there is a
meiosis-specific paralog of SMC1α, SMC1β [29], as well
as the meiosis-specific SA3/STAG3 subunit [30].
Making the sense of the multitude of cohesin subunits
is becoming objectively more and more difficult. Re-
cently, three groups characterized the RAD21L (RAD21-
like) protein, which is yet another meiosis-specific
cohesin subunit [31-33]. RAD21L is expressed strictly in
germline, i.e. in spermatocytes and oocytes. The pres-
ence of putative RAD21L complexes in the repertoire of
meiotic cohesins significantly increases the level of po-
tential complexity in the task of defining separate types
of cohesin complexes in meiosis. A recent review on the
subject estimates that there are 18 potential cohesincomplexes (Figure 1) that could be present in cells,
based on purely combinatorial considerations [34]. How-
ever, RAD21L cohesin complexes appear to come in
only two forms in vivo: with SMC3 and STAG3
complexed with either SMC1α or SMC1β [31,35,36].
Rad21L appears at chromosomes in germline lineage in a
fashion coordinated with REC8, at the pre-meiotic S phase.
It resides on chromosomes from the establishment of SCC,
through pairing of homologues and the establishment of
the synapsis. More specifically, RAD21L appears to
colocalize with axial elements upon meiosis initiation.
Then, when homologues synapse, RAD21L stays associated
with the synaptonemal complex all the way to the end of
pachytene, when it disappears from the still persisting syn-
aptonemal complex, according to [31]. However, there is
some disagreement on the exact time of RAD21L dis-
appearance [35], which is not possible to resolve based on
purely cytological data. It is quite possible that REC8 is ac-
tually trailing RAD21L in chromosome loading in lepto-
tene, making RAD21L the chief interface between cohesin
and the initiation of synapsis. Upon cohabitation with
REC8 the two proteins appear to enrich chromosomes in
an alternating pattern [32], although high-resolution chro-
matin mapping data is required to confirm that that pattern
is truly mutually exclusive.
The release of RAD21L from synaptonemal complex
also coincides with the emergence of MLH1 foci at
crossover sites. Thus, after the genetic recombination is
finished, RAD21L leaves chromosomes, parting its ways
with REC8, which stays bound at the axes of recombined
chromosomes. As a result, RAD21L is apparently absent
or has only marginal presence on chromosomes when
they commit to segregation in meiosis I. This prompted
a speculation that the RAD21L-containing cohesin rep-
resents the first case of cohesin complex which, at large,
is actually uninvolved with SCC per se. Such a conclu-
sion is indirectly supported by the observation that some
of RAD21L loading onto chromosomes, apparently via
the replacement of RAD21, in late pachytene may be
replication independent [31,32], i.e. happens after SCC
establishment. However, if a direct exchange of RAD21
to RAD21L exists in situ, the situation becomes more
complex to decipher. In any case, it would be premature
to draw conclusions on any non-SCC function of
RAD21L cohesin based solely on antibody staining data,
without detailed molecular analysis and in the absence
of mapping the distinct cohesin complexes in meiotic
chromatin with high resolution.
RAD21L cohesin complexes are involved in
homologue pairing
The peculiar dynamics of chromosomal associations of
RAD21L indicates that it may have a direct molecular
role in homologue pairing. Alternatively, RAD21L and
Figure 1 Cohesin complexes based on all possible combinations of known cohesin subunits. Meiosis-specific complexes are boxed in blue,
and mitotic, which are also found in meiosis, are boxed in red. The complexes that were not validated biochemically are shown shaded.
(*) Interaction of REC8 with SA/STAG subunits has not been studied exhaustively in mammalian systems.
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somal regions marked by other epigenetic marks facili-
tating pairing. Such marks may also themselves
predestine theses regions to either undergo recombin-
ation or to be refractory to it. Indeed, the pattern of al-
ternation of Rad21L and REC8 on meiotic chromosomes
creates an appearance of a “barcode” [31,32]. The func-
tionality of this “barcode” is awaiting the investigation.
While pre-mitotic bar-coding remains a hypothesis, the
direct role of RAD21L cohesin complex in homologue
pairing is supported by cytological data. Namely,
RAD21L, unlike other known cohesin subunits, does
interact physically with SYCP1, a component of the syn-
aptonemal complex. SYCP1 forms axial elements of thesynaptonemal complex at the beginning of the pathway
resulting in recognition and pairing of homologues [37].
While pairing of homologues is a feature of all eukary-
otes with a meiotic cycle, RAD21L is present in verte-
brates only. Unfortunately, however, little data on this
protein is available in non-mammalian systems. In mam-
mals, it is clear that at least some RAD21L cohesin com-
plexes do colocalize as well as show signs of physical
interaction with the proteins of axial elements, SYCP3
and SYCP2 [38,39]. Mouse genetic data allow one to
make the functional connection between cohesin sub-
units, axial elements’ structure, and genetic recombin-
ation itself. Single-gene knock-outs of Smc1β, Rec8 and
Rad21L show that spermatocytes arrest at the stage
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assembling axial elements and achieving a partial syn-
apse between homologues [29,33,36,40]. When both
Rec8 and Rad21L are deleted in mice, spermatogenic
cells get arrested at a stage corresponding to leptotene,
with chromosomes showing no pairing, apparently as a
result of axial elements dysfunction. This stage approxi-
mately corresponds to the stage IV among the twelve
morphological phases of seminiferous epithelium pro-
gression towards spermiogenesis. Spermatocytes with
such a double knockout (dKO) stay viable up to that
stage but later disappear, apparently as a result of arrest-
induced apoptosis [36]. Such a dramatic meiotic defect
of dKO has an inevitable consequence of infertility, i.e. all
dKO males are sterile, visibly lacking any post meiotic
cells in their seminiferous tubules, and with three-fold re-
duction in total testis size (at the age 6–8 week). While
this phenotype is quite severe, it appears to be largely
additive of similar defects in Rec8-deleted and Rad21L-
deleted mice [33,36,40], indicating that REC8 cohesin
complexes and RAD21L-containing complexes are spe-
cialized rather strictly.
In Rec8-Rad21L dKO spermatocytes, SYCP3 and
SYCP2 fail to localize to chromosomes and the forma-
tion of axial elements is impaired. A punctate SYCP3
and/or SYCP2 staining reveals the accumulation of ag-
gregates, which are devoid of SYCP1 [36]. However,
chromosomes in mouse Sycp1-Sycp3 dKO are still
loaded with meiotic cohesin complexes, and the synapsis
as well as recombination initiation both occur in such
meiotic cells [41]. The sum of phenotypic analyses un-
equivocally indicates that either meiotic cohesin com-
plexes are essential for the initiation of axial elements
and the assembly of lateral elements or themselves are
bona fide components of axial elements [36].
For understanding the underlying physiological abnor-
malities in dKO Rad21L and Rec8 males mice it is im-
portant to consider that spermatocytes are not only
defective in axial elements assembly, but are also unable
to initiate a specific recombination pathway mediated by
RAD51. This defect is signified by up to ten-fold reduc-
tion in RAD51 foci numbers observed in spermatocytes
[36]. RAD51 normally assembles on bivalents within
axial elements and lateral elements in leptotene and dis-
appears later from all chromatin that was synapsed [42].
However, the number of DMC foci was unaffected in
leptonema of the dKO spermatocytes, as well as the
DMC1-dependent repair of DSB, which dKO generated
(likely by SPO11) with normal frequency, was largely un-
affected. Despite that, some repair detected by gamma-
H2AX staining appeared to persist in chromosomes of
arrested dKO spermatocytes [36]. This indicates either
that the normal meiotic DMC pathway is partially
perturbed, or that DSB were generated by a non-physiological mechanism. Taken together, this dKO
spermatocyte phenotype indicates that while physio-
logical DSBs priming recombination events are induced
with normal frequency and kinetics, RAD21L and REC8
complexes are evidently involved in cooperative non-
redundant pathways leading to axial elements formation
followed by the assembly of the synaptonemal complex
[36]. A direct involvement of meiotic cohesin complexes
in genetic recombination may have substantial implica-
tions for cancer cells that express these proteins.
Why another cohesin? Spermatogenesis vs
oogenesis
KO of both Rad21L and Rec8 in mice should have left
the somatic cohesin fully intact in meiocyte lineage.
Early binding of RAD21 to chromatin is indicative of its
involvement in the establishment of SCC in the S phase
preceding the meiosis [36]. Indeed, the proper establish-
ment of SCC in the premeiotic S-phase seems unper-
turbed, by cytological criteria, while RAD21 remains
chromosome-bound from leptonema to diplonema (or
until pachytene in [32]) in mouse spermatocytes [36].
These observations seemingly suggest that meiotic
cohesin complexes are not required for SCC, at least not
as much as for their other functions, i.e. synaptonemal
complex formation. On the other hand, in a specialized
meiotic system in marsupials, STAG3 (most likely as a
part of the incorporating cohesin complex) is involved in
segregating sex chromosomes that undergo no recombin-
ation. This is achieved via assembly of a unique structure
called dense plate [43]. These two polar considerations,
i.e. the apparent un-involvement in SCC in mice and
the participation in meiotic segregation that does not
involve any recombination, both indicate that meiotic
cohesins occupy a rather specialized niche in meiosis.
The exact degree of meiotic specialization of the three
types of cohesin complexes built around RAD21,
RAD21L or REC8 remains to be fully uncovered, how-
ever such a task may involve more than just analyzing
the meiotic prophase. Indeed, their chromatin binding
properties and turnover not just vary in the first pro-
phase; they also behave differently through metaphases
of both the first and the second meiotic divisions. The
latter includes a substantial enrichment of RAD21L at
centromeres at the metaphase II [33]. RAD21L is also
the first cohesin subunit with a strong sex-dependent
phenotype resulting from its inactivation. This some-
what challenges the hypothesis that the corresponding
cohesin has a universal, essential and direct role in
homologue pairing. In the context of such a hypothesis,
it is difficult to explain why RAD21L appears to be dis-
tinctly distributed in male and female germlines.
Namely, in the metaphase of meiosis I in spermatocytes,
RAD21L is apparently left at the centromeres, while in
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[32]. This difference is not likely to be purely technical.
Instead, it may either reflect a deep biological difference
or stem from the distinctly differential dynamics of mei-
oses in male and female germlines [44].
Genetic data also strongly indicate that RAD21L func-
tion is distinct in male and female germlines. RAD21L
cohesin complex may be sex-restricted in its function,
even though other meiotic cohesin subunits that were
mutated did not show such a severe dichotomy. For ex-
ample, SMC1β depletion leads to sterility in both males
and females. However, the SMC1β-devoid mouse sper-
matocytes undergo an arrest in pachytene, while oocytes
only suffer precocious dissolution of SCC during meiotic
metaphase II [45]. Upon REC8 inactivation, both sexes
in mice show sterility correlating with the impaired syn-
apsis of homologues and the defective formation of chi-
asmata [40,46]. At the same time, germ cells of male
Rad21L−/− mice, as was mentioned, cannot achieve the
complete synapsis of homologous chromosomes during
the first meiotic prophase. As a result of this defect, and
possibly others yet to be uncovered, spermatocytes run
into zygotene arrest leading to the complete absence of
spermatozoa. In contrast, female mice lacking RAD21L
are fertile, but develop sterility at the age of 6 months.
The molecular basis of this aging process is yet to be
understood, as the original report seemingly excluded a
probable defect in SCC as the leading cause, and the
synapsed bivalents in KO females apparently have wild
type amount of STAG3 loaded [33]. Furthermore, it ap-
pears that this difference between the sexes is not
dependent on the differential regulation of meiotic
checkpoints in males and females, particularly in relation
to dictyate. Rather, this difference could be a reflection
of the fact that RAD21L is not involved in homologue
segregation in mouse oogenesis [33]. Thus, for RAD21L,
we have evidence of both the sex-limited specialization
and the redundancy with REC8. The latter is possibly
reflected in evolutionary data that strongly suggest that
only mammals need both proteins simultaneously, as
RAD21L is not present in amphibians, while REC8 is ab-
sent in birds [35].
In the absence of data from non-mammal vertebrates
it is not possible to judge whether such differences really
represent the sex-specific functional properties of mei-
otic cohesins themselves, or result from a differential
chromatin organization in sexes of placental animals.
The latter, could be due to potentially differential roles
of the global transcriptional regulator and chromatin-
structuring factor CTCFL/BORIS in mammalian sper-
matocytes and oocytes [47,48]. Indeed, in adult mouse
testis, the CTCF paralog BORIS/CTCFL is expressed,
likely transiently, in late spermatogonia and in the pre-
leptotene germ cells [49]. An answer to the questionwhether BORIS/CTCFL facilitates, even if partially,
RAD21L localization in male meiosis, considering that
RAD21 notably co-localizes with CTCF in soma, will
likely linger until one generates high resolution chroma-
tin maps for meiotic cohesin complexes and compare
them to the recent chromatin immunoprecipitation
maps of CTCF and CTCFL in the germline [49].
Cancer connection
The reference to CTCFL/BORIS brings about an import-
ant connection of some meiotic proteins to cancers. In-
deed, germline-specific CTCFL/BORIS is aberrantly
activated in many tumors and cancer cell lines [48,50,51],
and its presence there was largely overlooked by the litera-
ture devoted to CTCF-cohesin colocalization in cancer
cells of somatic origin. On the other hand, in the past
several years it became evident that chromosome
destabilization, as a result of mutation or epimutation,
is likely one of the earliest steps in transforming a nor-
mal somatic cell into a cancer cell [52,53]. Cohesin de-
regulation, in particular, may provide a rich potential
source of such destabilizing changes, as the failure to
resolve sister chromatid cohesion in mitosis universally
results in chromosomal damage [54]. Indeed, both mu-
tations of separase [55] and somatic cohesin subunits
SMC1L1 and SMC3/CSPG6 themselves were correlated
with tumors [56]. Tumor-borne mutations were also
identified in the putative cohesin loader SCC2/NIPBL
as well as in STAG3 [56]. COSMIC database of cancer
genomic data contains 15 examples of mutations in
RAD21L, some of them reoccurring, 83 mutations in
SMC1β, and 88 in STAG3. While REC8 activation in som-
atic cells has not been reported, its differential methylation
was linked to poor cancer prognoses in gastrointestinal
stromal tumor [57]. Similarly to RAD21L and REC8, the
expression of SMC1β and STAG3 are known to be tran-
scriptionally silenced in somatic cells, and this repression
involves a set of diverse mechanisms, such as methylation
of histone H3 on both lysine 9 and lysine 27 [58]. Despite
such safeguards preventing the transcription of meiotic
cohesin subunits in soma, RAD21L and other meiotic
cohesin proteins are known to be aberrantly activated in
cancers and thus fall into a special group of factors named
Cancer/Testis genes, and Antigens [59-61]. RAD21L,
SMC1β and STAG3 subunits have drastically distinct pat-
terns of activation/overexpression in cancers, however.
STAG3 activation is found practically in every dataset in
Oncomine (September 2012 release), including all types of
cancers, with some of datasets showing over 50% of sam-
ples overexpressing STAG3 over 2-fold. On the contrary,
SMC1β is only expressed (over 2 fold increase over base-
line) in 3.4% of samples in the same Oncomine release
(public datasets), mostly in invasive breast carcinomas,
and RAD21L is only found in 5 samples using the same
Strunnikov Cell Regeneration 2013, 2:4 Page 6 of 8
http://www.cellregenerationjournal.com/content/2/1/4cutoff. This indicates that the potential misregulation of
somatic cohesin by STAG3 is a common event in cancers,
while the expression of full meiotic cohesin, to include
SMC1β and RAD21L, appears to be rare. It must be
noted, however, that the baseline in gene expression ex-
periments in somatic cancers may have been too high to
detect a biologically meaningful activation of SMC1b and
RAD21L. Furthermore, when the experimental approach
is specifically targeted at CT genes, the outcome could be
quite different. For example in a recently published
dataset of only 33 cancer cell lines, six were shown to ex-
press RAD21L, with two co-expressing SMC1b with
RAD21L [62]. Thus, as cohesin functions are intimately
intertwined with chromosome segregation mechanisms,
meiotic subunits could potentially serve as the source of
epimutations leading to chromosome instability in can-
cers, especially considering how many “unnatural” com-
plexes could be formed (Figure 1).
Among the biological and mechanistic questions about
the nature of meiotic cohesins’ involvement in chromo-
some recombination and segregation in the norm, three
especially stand out with respect to cancer biology. First,
it is important to study whether somatic cohesin’s prop-
erties in vivo are altered upon STAG3 binding, as
STAG3 activation and overexpression is a common
event in multiple cancers. Second, it would be useful to
determine whether the SMC1β-SMC3-RAD21L-STAG3
complex is actually able to participate in SCC. Third, it
would be important to know whether RAD21L is cleav-
able by separase. If meiotic cohesin is able to establish
SCC in principle, as the experimental results seemingly
suggest, then a cancer cell where these proteins are acti-
vated may have a problem in resolving SCC in anaphase,
recapitulating a well-characterized defect in SCC reso-
lution [54]. This could only happen, if the meiosis-
specific regulation of cohesin removal or a hypothetical
RAD21L cleavage is not in place in mitosis in such can-
cer cells. It is plausible however, that mitotic prophase
cohesin removal pathway mediated by PLK1 could re-
move RAD21L complexes in cancer cells similarly to the
corresponding pathway engaged in meiosis I [32]. Never-
theless, the absence of cleavage of residual RAD21L
complexes, particularly at centromeres where they can
be targeted based on meiotic data [33], may pose a sig-
nificant hurdle for chromosome segregation. Experimen-
tal investigation of these questions is feasible. While the
ectopic expression of individual components of meiotic
cohesin in cell lines does not appear to cause dramatic
defects, neither correct stoichiometry was modeled nor
detailed phenotypic analysis was performed in these
studies with respect to chromosomes [35]. There were
also no reports on the ectopic co-expression of all three
meiotic subunits, SMC1β, STAG3 and RAD21L, in som-
atic cells.Cancer cells may, however, lack the regulatory machin-
ery to fully engage subunits of meiotic cohesin complexes,
either ectopically expressed or aberrantly activated. It was
recently reported that SMC3, STAG3, and REC8, as well
as interacting factors SYCP2, SYCP3, HORMAD1, and
HORMAD2, are specifically phosphorylated in the pro-
phase I [63]. In case of SMC3, for example, the form phos-
phorylated at an ATM/ATR consensus mostly localizes to
disjoined homologues’ regions, prior to synapsis. Further-
more, this regulation is probably tied into the DSB forma-
tion pathway, as SPO11 is required for it to occur [63].
Thus the experimental testing of the functionality of aber-
rantly activated meiotic cohesin is essential for under-
standing its molecular role in cancer cells.
Notwithstanding only limited information on the func-
tionality of meiotic cohesin subunits in tumor cells, it is
unlikely that their activation has an adaptive benefit for
cell proliferation. On the contrary, such events are prob-
ably detrimental for chromosome integrity and segrega-
tion fidelity. Therefore, it is possible that the activation
of meiotic cohesin genes in soma is involved in the earl-
ier stages of tumorigenesis, thus providing a set of more
universal targets for potential therapy compared to adap-
tive late-onset tumor mutations. Cancer/Testis genes
were indeed reported as promising targets for the im-
munotherapy of cancer in model systems and in humans
[64-66]. This strategy benefits from the tight repression
of corresponding genes in soma, which enables one to
diminish or eliminate potential side effects of treatments
targeting these proteins. The activation of meiotic
cohesin subunits may also provide an attractive target to
find synthetic treatments targeting their combinations
with other common mutations in cancers, especially
ones in DNA damage response pathways.
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